Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ladisch

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Blood Advances|May 13, 2026
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosisBarbara A Degar, Oussama Abla, Patrick K Campbell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseasesJonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
Blood Advances|August 30, 2021
IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRSHoward Lin, Brooks P Scull, Baruch R Goldberg, et al.
Cancer|April 30, 2024
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational curesKevin Bielamowicz, Peter Dimitrion, Oussama Abla, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Blood Advances|May 13, 2026
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosisBarbara A Degar, Oussama Abla, Patrick K Campbell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseasesJonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
Blood Advances|August 30, 2021
IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRSHoward Lin, Brooks P Scull, Baruch R Goldberg, et al.
Cancer|April 30, 2024
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational curesKevin Bielamowicz, Peter Dimitrion, Oussama Abla, et al.
Pageof 5